Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Dicerna Sells OXLUMO Royalty Interest to Royalty Pharma for Up to $240M; Dicerna To Receive $180M Upfront and Up to $60M in Potential Additional Milestone Payments


Benzinga | Apr 8, 2021 07:31AM EDT

Dicerna Sells OXLUMO Royalty Interest to Royalty Pharma for Up to $240M; Dicerna To Receive $180M Upfront and Up to $60M in Potential Additional Milestone Payments






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC